Skip to main content

Loblaw Companies Ltd. is looking to sell recreational marijuana in Newfoundland and Labrador, as the provincial body handling pot sales has included the company on its list of potential licensed cannabis retailers.

Cannabis NL, a division of the Newfoundland Labrador Liquor Corp., on Monday released its list of qualified retailer applicants which have been selected for the next phase of the application process.

Loblaw’s applications for 10 potential locations were among the 24 selected by Cannabis NL. Other applicants on the list included licensed medical marijuana producer Canopy Growth, regional health store chain the Healthy Vibe, and Tobin’s Convenience.

Story continues below advertisement

Lobaw’s presence in Newfoundland and Labrador includes grocery stores under the Dominion banner and Shoppers Drug Mart locations.

Company spokeswoman Catherine Thomas said the retailer does not plan to sell recreational cannabis on its grocery store shelves in the province.

“It would be available behind the counter, in small, existing tobacco shops, adjacent but separate to our Dominion grocery stores,” Thomas wrote in an emailed statement.

Cannabis NL said the Newfoundland Labrador Liquor Corp. will be in touch with applicants in the coming days to determine the next steps in the process.

Loblaw first applied for a license to dispense medical marijuana in 2016. Shoppers Drug Mart has lined up supply deals with several licensed medical marijuana producers including Aurora Cannabis and Aphria, which are subject to Health Canada’s approval of its application.

Loblaw has said medical marijuana is their focus, but their CEO has also said that the retailer is open to being involved with recreational marijuana.

Thomas said Monday that while Loblaw has been named among the qualified applicants to sell recreational pot, “there are more steps to come and it’s premature to discuss details or outcomes.”

Story continues below advertisement

“This has nothing to do with Shoppers Drug Mart or our application to distribute medical cannabis, which remains our focus,” she said.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter